At the University of York, we are lucky to have one of the largest groups of researchers working on leishmaniasis in the UK.

  • Professor Paul Kaye
    Professor of Immunology

    Paul Kaye is Professor of Immunology at the University of York, and has worked for over 30 years on the immunology and immunopathology of the neglected tropical disease leishmaniasis

  • Professor Jeremy Mottram
    Director of the York Biomedical Research Institute

    Jeremy Mottram works on the molecular genetics, cell biology and biochemistry of Leishmania. His primary research goal is to understand the molecular mechanisms by which Leishmania progresses through its complex life cycle in insect and mammalian hosts.

  • Dr Pegine Walrad
    Research Lecturer in Molecular Parasitology, Department of Biology

    Pegine Walrad is a Research Lecturer in Molecular Parasitology appointed to the Centre for Immunology and Infection in the Department of Biology in honour of the University of York’s 50th Anniversary.

  • Professor Rachel Churchill
    Professor in Evidence Synthesis within CRD

    A psychiatric epidemiologist and mental health services researcher, dedicated to improving healthcare decision-making with people experiencing mental health problems.

  • Professor Gideon Davies
    Royal Society Ken Murray Research Professor

    Gideon Davies works on the biosynthesis of the unusual "mannogen" storage polysaccharide of Leishmania, the panel of enzymes involved and how they are linked to virulence.

  • Dr Martin Fascione
    Lecturer, Department of Chemistry

    Martin Fascione is a chemical biologist with a focus on developing “chemical medicine” approaches to combat and study the biological mechanisms of disease, specifically focussing on glycosylation and other post-translational modifications, including lipidation in Leishmania.

  • Professor Ian Hitchcock
    Professor of Experimental Haematology

    Ian Hitchcock investigates how Leishmania infections cause haematological disorders, in particular thrombocytopenia (low platelet counts) which can lead to infection-related bleeding complications.

  • Dr Daniel Jeffares
    Lecturer, Department of Biology

    Daniel Jeffares studies the population genomics of Leishmania species. He uses population and quantitative genetics to describe the history, demography and evolution of the parasites on a global scale.

  • Dr Nathaniel Jones
    GCRF NTD Network Research Fellow, Department of Biology

    Nathaniel is working to validate epigenetic reader proteins of Leishmania as new drug targets. Several of these targets are being characterised using genetic, proteomic, biochemical and structural techniques.

  • Professor Charles Lacey
    Professor of Medicine at Hull York Medical School

    Charles Lacey works on (i) developing a human challenge model of Leishmania major and (ii) clinical evaluation of the York ChAd63-KH Leishmaniasis vaccine as a prophylactic and therapeutic agent. Our primary goal is to develop safe and effective vaccines against Leishmania.

  • Dr Dimitris Lagos
    Senior Lecturer in Immunology

    Dimitris Lagos is a molecular immunologist studying the mechanisms governing immune gene expression. He studies immune responses to Leishmania with a view to developing host-based interventions and cutting-edge molecular pathology pipelines.

  • Dr Alison Layton
    Honorary Clinical Senior Lecturer at Hull York Medical School

    Dr Alison Layton, M.B;Ch.B.; FRCP was appointed as a Consultant Dermatologist at Harrogate and District NHS Foundation Trust and Honorary Clinical Senior Lecturer at Hull York Medical School.

  • Default thumbnail

    Dr Elmarie Myburgh
    Lecturer, Hull York Medical School

    Elmarie Myburgh is a lecturer in Immunology and Infection whose role includes teaching and research related to host-pathogen interactions, immunoregulation and drug discovery.

  • Dr Damian Eduardo Perez Mazliah
    Fellowship in Immunology, Hull York Medical School

    Generation of long-lasting and protective B-cell responses underpin the success of most vaccines, yet production of vaccines to protozoan parasites remains extremely challenging. Damian is currently studying the mechanisms and signals that orchestrate B-cell responses to Leishmania parasites.

  • Dr Jon Pitchford
    Senior Lecturer in mathematical ecology

    Jon Pitchford is a mathematical biologist with research interests in nonlinear dynamics and random processes. He works with a wide range of Leishmaniasis scientists at York, seeking to understand the mechanisms driving infection and transmission.

  • Dr Ben Powell
    Lecturer, Department of Mathematics

    Ben Powell contributes to the group's work by developing statistical methods for understanding and predicting the behaviour of the Leishmania parasite.

  • Dr Paul Revill
    Senior Research Fellow, Centre for Health Economics

    Paul Revill is a health economist who works on issues of health care organization and resource allocation, particularly with a focus on Africa. The aim of his work is to ensure resources committed to health care are spent in ways likely to lead to improvements in population health and wellbeing, recognizing the complexities of health care funding and delivery.

  • Professor Mark Sculpher
    Professor of Health Economics

    Mark Sculpher has been part of a team thinking about the economics of Leishmania and the potential cost-effectiveness of new prevention and treatment interventions.

  • Default thumbnail

    Dr Katrien Van Bocxlaer
    Research Fellow in Drug Discovery, Department of Biology

  • Professor Tony Wilkinson
    Professor, Department of Chemistry

    Tony Wilkinson works on structure and function of drug targets in Leishmania collaborating with parasitologists and medicinal chemists. The primary targets are enzymes involved in post-translational modification including protein lipidation/acetylation, protein phosphorylation and protein ubiquitination.

  • Professor Barry Wright
    Professor of Child Mental Health

    Barry Wright is interested in associations between mental health and physical diseases such as Leishmania.